Cargando…

Characteristics of mutational signatures of unknown etiology

Although not all somatic mutations are cancer drivers, their mutational signatures, i.e. the patterns of genomic alterations at a genome-wide scale, provide insights into past exposure to mutagens, DNA damage and repair processes. Computational deconvolution of somatic mutation patterns and expert c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiaoju, Xu, Zhuxuan, De, Subhajyoti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520824/
https://www.ncbi.nlm.nih.gov/pubmed/33015626
http://dx.doi.org/10.1093/narcan/zcaa026
_version_ 1783587853716946944
author Hu, Xiaoju
Xu, Zhuxuan
De, Subhajyoti
author_facet Hu, Xiaoju
Xu, Zhuxuan
De, Subhajyoti
author_sort Hu, Xiaoju
collection PubMed
description Although not all somatic mutations are cancer drivers, their mutational signatures, i.e. the patterns of genomic alterations at a genome-wide scale, provide insights into past exposure to mutagens, DNA damage and repair processes. Computational deconvolution of somatic mutation patterns and expert curation pan-cancer studies have identified a number of mutational signatures associated with point mutations, dinucleotide substitutions, insertions and deletions, and rearrangements, and have established etiologies for a subset of these signatures. However, the mechanisms underlying nearly one-third of all mutational signatures are not yet understood. The signatures with established etiology and those with hitherto unknown origin appear to have some differences in strand bias, GC content and nucleotide context diversity. It is possible that some of the hitherto ‘unknown’ signatures predominantly occur outside gene regions. While nucleotide contexts might be adequate to establish etiologies of some mutational signatures, in other cases additional features, such as broader (epi)genomic contexts, including chromatin, replication timing, processivity and local mutational patterns, may help fully understand the underlying DNA damage and repair processes. Nonetheless, remarkable progress in characterization of mutational signatures has provided fundamental insights into the biology of cancer, informed disease etiology and opened up new opportunities for cancer prevention, risk management, and therapeutic decision making.
format Online
Article
Text
id pubmed-7520824
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-75208242020-10-01 Characteristics of mutational signatures of unknown etiology Hu, Xiaoju Xu, Zhuxuan De, Subhajyoti NAR Cancer Short Review Although not all somatic mutations are cancer drivers, their mutational signatures, i.e. the patterns of genomic alterations at a genome-wide scale, provide insights into past exposure to mutagens, DNA damage and repair processes. Computational deconvolution of somatic mutation patterns and expert curation pan-cancer studies have identified a number of mutational signatures associated with point mutations, dinucleotide substitutions, insertions and deletions, and rearrangements, and have established etiologies for a subset of these signatures. However, the mechanisms underlying nearly one-third of all mutational signatures are not yet understood. The signatures with established etiology and those with hitherto unknown origin appear to have some differences in strand bias, GC content and nucleotide context diversity. It is possible that some of the hitherto ‘unknown’ signatures predominantly occur outside gene regions. While nucleotide contexts might be adequate to establish etiologies of some mutational signatures, in other cases additional features, such as broader (epi)genomic contexts, including chromatin, replication timing, processivity and local mutational patterns, may help fully understand the underlying DNA damage and repair processes. Nonetheless, remarkable progress in characterization of mutational signatures has provided fundamental insights into the biology of cancer, informed disease etiology and opened up new opportunities for cancer prevention, risk management, and therapeutic decision making. Oxford University Press 2020-09-25 /pmc/articles/PMC7520824/ /pubmed/33015626 http://dx.doi.org/10.1093/narcan/zcaa026 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of NAR Cancer. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Review
Hu, Xiaoju
Xu, Zhuxuan
De, Subhajyoti
Characteristics of mutational signatures of unknown etiology
title Characteristics of mutational signatures of unknown etiology
title_full Characteristics of mutational signatures of unknown etiology
title_fullStr Characteristics of mutational signatures of unknown etiology
title_full_unstemmed Characteristics of mutational signatures of unknown etiology
title_short Characteristics of mutational signatures of unknown etiology
title_sort characteristics of mutational signatures of unknown etiology
topic Short Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520824/
https://www.ncbi.nlm.nih.gov/pubmed/33015626
http://dx.doi.org/10.1093/narcan/zcaa026
work_keys_str_mv AT huxiaoju characteristicsofmutationalsignaturesofunknownetiology
AT xuzhuxuan characteristicsofmutationalsignaturesofunknownetiology
AT desubhajyoti characteristicsofmutationalsignaturesofunknownetiology